Series B funding round for Silverback Therapeutics raising $79M in March 2020
Series B funding round for Silverback Therapeutics raising $79M in March 2020
| Investor | Firm Type | Partner |
|---|---|---|
| Venture Capital |
| — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
This company has completed 2 funding rounds. Current round is highlighted.
Total Raised
$164M
Top Valuation
-
Silverback Therapeutics raised $79M in a Series B round.
The round was announced on 03/01/20.